Patents by Inventor Jurgen Eck

Jurgen Eck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180016543
    Abstract: A method of producing yeast mutants and the use thereof. In order to provide yeasts which, at a given sugar content, produce a low ethanol content and a relatively high glycerol content in ethanolic fermentation and which are simultaneously obtainable rapidly, at least one yeast strain is contacted in a first mutagenesis step with a first mutagen and in a second mutagenesis step with a second mutagen. The first and second mutagens are different from one another and are selected from the following groups: nucleotide-alkylating agent, nucleotide-deaminating agent, and UV radiation. The method further includes a first selection step executed between the first and second mutagenesis steps and a second selection step being executed after the second mutagenesis step, in which the mutants that originate from the prior mutagenesis step in each case are exposed to a selection factor selected from the following groups: (a) hypertonic medium and (b) alcohol dehydrogenase inhibitor.
    Type: Application
    Filed: February 4, 2016
    Publication date: January 18, 2018
    Applicants: Erbslöh Geisenheim AG, BRAIN AG
    Inventors: Jürgen FRÖHLICH, Jürgen ECK, Guido MEURER, Christian NAUMER, Jörg BÜSCHER, Jörg MAMPEL
  • Patent number: 9353386
    Abstract: The present invention relates to a host cell having an elevated expression or activity of an enzyme as compared with the parent cell from which it has been derived, said enzyme having lactoyl-CoA reductase activity. Furthermore, provided is a method of producing lactaldehyde and/or 1,2-propanediol, said method comprising culturing said host cell and/or utilizing said enzyme to produce said compound.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: May 31, 2016
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Daniel Koch, Guido Meurer, Jürgen Eck
  • Patent number: 9193961
    Abstract: The present invention relates to a polynucleotide encoding an enzyme having carboxylesterase [E.C.3.1.1.1] activity.
    Type: Grant
    Filed: May 3, 2007
    Date of Patent: November 24, 2015
    Assignee: B.R.A.I.N. AG
    Inventors: Klaus Liebeton, Jürgen Eck, Uwe Bornscheuer, Dominique Böttcher, Peter Langer, Esen Bellur
  • Patent number: 8993743
    Abstract: The present invention relates to a nucleic acid molecule encoding a chimeric protein having the biochemical activity of a surface active protein, wherein said chimeric protein comprises: (a) an N-terminal portion of a first surface active protein, wherein the N-terminal portion is devoid of between 0 and 10 of the most N-terminal amino acids of the mature first surface active protein; and, C-terminally thereof, (b) a C-terminal portion of a second surface active protein, wherein the C-terminal portion is devoid of between 0 and 10 of the most C-terminal amino acids of the mature second surface active protein. The present invention further relates to a vector, a non-human host and a method for the production of a chimeric protein having the biochemical activity of a surface active protein. In addition, the present invention relates to a chimeric protein encoded by the nucleic acid molecule of the invention and a composition comprising the chimeric protein.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: March 31, 2015
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Guido Meurer, Esther Gabor, Anke Bachert, Jürgen Eck
  • Patent number: 8790900
    Abstract: The invention relates to the biotechnological production of isomaltulose and isomaltulose-containing compositions and improved means, therefore particularly microbial cells.
    Type: Grant
    Filed: October 23, 2010
    Date of Patent: July 29, 2014
    Assignee: Südzucker Aktiengesellschaft Mannheim/Ochsenfurt
    Inventors: Stefan Pelzer, Christian Zurek, Thomas Rose, Jürgen Eck, Wolfgang Wach, Michael Klingeberg, Karsten Harms
  • Publication number: 20140178953
    Abstract: The present invention relates to a host cell having an elevated expression or activity of an enzyme as compared with the parent cell from which it has been derived, said enzyme having lactoyl-CoA reductase activity. Furthermore, provided is a method of producing lactaldehyde and/or 1,2-propanediol, said method comprising culturing said host cell and/or utilizing said enzyme to produce said compound.
    Type: Application
    Filed: June 15, 2012
    Publication date: June 26, 2014
    Applicant: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG
    Inventors: Daniel Koch, Guido Meurer, Jürgen Eck
  • Patent number: 8679829
    Abstract: The present invention relates to a sulfolobus expression vector comprising: (a) sulfolobus origin of replication; (b) the genes encoding the structural proteins and the site-specific integrase of SSV1, SSV2 or pSSVx, operatively linked to expression control sequences and a packaging signal; (c) one or more selectable marker gene(s), operatively linked to sulfolobus expression control sequences; and (d) a sulfolobus promoter followed 3? by a restriction enzyme recognition site or a multiple cloning site for insertion of a gene of interest and optionally a 3? regulatory element. Moreover, the present invention relates to a shuttle vector comprising the sequences of the expression vector of the invention and additional sequences for propagation and selection in E. coli, wherein the additional sequences comprise (a) an E. coli on of replication; and (b) a marker for selection in E. coli.
    Type: Grant
    Filed: June 2, 2004
    Date of Patent: March 25, 2014
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Christa Schleper, Melanie Jonuscheit, Jürgen Eck, Frank Niehaus, Sonja-Verena Albers, Sabrina Froels
  • Patent number: 8623810
    Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: January 7, 2014
    Assignee: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn
  • Patent number: 8470576
    Abstract: The present invention provides a polynucleotide or a pair of polynucleotides encoding an enzyme having nitrile hydratase (NHase) [E.C. 4.2.1.84] activity. Furthermore, a vector and a host comprising the disclosed polynucleotide or pair of polynucleotides and methods for the production of the same are provided. Moreover, the invention relates to a pair of polypeptides or a fusion protein having NHase activity, an antibody specifically binding to the pair of polypeptides or fusion protein, a primer or probe, which specifically hybridizes under stringent conditions to the disclosed polynucleotide or either one of the pair of polynucleotides, a composition comprising the polynucleotide or pair of polynucleotides, the pair of polypeptides or fusion protein, the antibody and/or one or more primers or probes of the invention and a method for the production of amides comprising the enantioselective conversion of nitriles.
    Type: Grant
    Filed: April 5, 2007
    Date of Patent: June 25, 2013
    Assignee: B.R.A.I.N. AG
    Inventors: Jürgen Eck, Klaus Liebeton, Lutz Fischer, Sabine Lutz-Wahl, Martina Hensel, Christian Ewert, Marcus Wälz
  • Patent number: 8455107
    Abstract: By treatment with hydrophobins, cellulosic materials such as paper, cardboard, cotton or, especially, wood-based materials, such as solid wood, glued wood products or particle board, can be effectively protected against absorption of and attack by water and/or moisture.
    Type: Grant
    Filed: February 27, 2008
    Date of Patent: June 4, 2013
    Assignee: BASF SE
    Inventors: Esther Gabor, Andreas Buthe, Jürgen Eck, Franz Kaufmann, Hans-Jörg Koch, Guido Meurer
  • Publication number: 20120225458
    Abstract: The invention relates to the biotechnological production of isomaltulose and isomaltulose-containing compositions and improved means, therefore particularly microbial cells.
    Type: Application
    Filed: October 23, 2010
    Publication date: September 6, 2012
    Applicant: SUDZUCKER AKTIENGESELLSCHAFT MANNHEIM/OCHSENFURT
    Inventors: Stefan Pelzer, Christian Zurek, Thomas Rose, Jürgen Eck, Wolfgang Wach, Michael Klingeberg, Karsten Harms
  • Publication number: 20120213764
    Abstract: The present invention relates to a method of producing a peptide consisting of the amino acids 63 to 110 of dermcidin (SEQ ID NO: 3) comprising (a) culturing a host cell carrying a nucleic acid molecule encoding the peptide in an expressible form, and (b) optionally isolating the peptide from the culture. Furthermore, the invention relates to a nucleic acid molecule encoding a fusion protein comprising or consisting of (a) a peptide heterologous with regard to dermcidin protein-tag; and, C-terminally thereof (b) a peptide having the antimicrobial activity of dermcidin wherein the fusion protein contains an arginine residue located immediately N-terminally of the peptide of (b).
    Type: Application
    Filed: September 22, 2010
    Publication date: August 23, 2012
    Applicant: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG
    Inventors: Christian Naumer, Michael Krohn, Yvonne Tiffert, Jürgen Eck
  • Patent number: 8226967
    Abstract: The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture of hydrophobins to galenic compositions or for treating the surface of pharmaceutical forms with a hydrophobin-containing solution to modify the pharmaceutical properties of the galenic form. In a preferred embodiment of the invention hydrophobins are used to improve the properties of a pharmaceutical composition, e.g. to act as a surfactant or to increase resistance to disintegration of the galenic forms to achieve a retarded drug release. The galenic form to be modified by the use of surface active proteins as excipients can be capsules, tablets, pills, microparticles, vesicles, and suppositories, although further galenic forms are envisioned.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: July 24, 2012
    Assignee: BASF SE
    Inventors: Andreas Buthe, Andreas Hafner, Franz Kaufmann, Esther Gabor, Guido Meurer, Jürgen Eck, Gordon Bradley
  • Publication number: 20120093788
    Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.
    Type: Application
    Filed: March 3, 2010
    Publication date: April 19, 2012
    Applicant: B.R.A.I.N. Biotechnology Research and Information Network AG
    Inventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn
  • Publication number: 20110268792
    Abstract: The invention relates to a use of surface active hydrophobins for applications in pharmaceutical technology, in particular as excipients for galenic use. Provided is a method for either admixture of hydrophobins to galenic compositions or for treating the surface of pharmaceutical forms with a hydrophobin-containing solution to modify the pharmaceutical properties of the galenic form. In a preferred embodiment of the invention hydrophobins are used to improve the properties of a pharmaceutical composition, e.g. to act as a surfactant or to increase resistance to disintegration of the galenic forms to achieve a retarded drug release. The galenic form to be modified by the use of surface active proteins as excipients can be capsules, tablets, pills, microparticles, vesicles, and suppositories, although further galenic forms are envisioned.
    Type: Application
    Filed: November 13, 2009
    Publication date: November 3, 2011
    Applicant: BASF SE
    Inventors: Andreas Buthe, Andreas Hafner, Franz Kaufmann, Esther Gabor, Guido Meurer, Jürgen Eck, Gordon Bradley
  • Publication number: 20110217232
    Abstract: A method for the determination of the responsiveness of an individual to mistletoe lectin or to (an) mistletoe lectin single chain(s), wherein the expression of a membrane-bound receptor for mistletoe lectin is characteristic of a corresponding responsiveness.
    Type: Application
    Filed: December 21, 2009
    Publication date: September 8, 2011
    Inventors: Johannes Muthing, Jasna Peter-Katalinic, Martin Langer, Babette Mockel, Jurgen Eck
  • Publication number: 20110124069
    Abstract: The invention relates to the development of microorganisms that produce 1,2-propanediol (1,2-PD) from glycerol, whereas glycerol is simultaneously the substrate carbon source for 1,2-PD- and biomass production. The invention demonstrates that any type of glycerol serves as carbon substrate for 1,2-PD biosynthesis. The microorganism is a recombinant organism, preferentially an E. coli K12 strain or a derivative thereof, particularly a strain, which is inactivated in competing pathways that lower 1,2-PD production.
    Type: Application
    Filed: July 16, 2009
    Publication date: May 26, 2011
    Inventors: Jorg Mampel, Guido Meurer, Jurgen Eck
  • Publication number: 20110105442
    Abstract: The present invention relates to a cosmetic composition for the cleaning of the skin, said composition comprising or consisting of one or more compounds of formula (I) wherein represents a single bond or double bond; R1 and R2 are independently selected from H, linear or branched C1 to C4 alkyl, linear or branched C1 to C4 alkenyl, linear or branched C1 to C4 alkinyl, and linear or branched C1 to C4 alkanoyl; R4 is selected from H, linear or branched C1 to C4 alkyl, linear or branched C1 to C4 alkenyl, and linear or branched C1 to C4 alkinyl; and R3 and R5 are independently selected from H, OH and halogen, or R3 and R5 together are O to form an epoxid, wherein represents a single bond in case R3 and R5 together are O. Also provided are means and methods for the prevention or reduction of biofilm formation on an intracorporeal device and/or for the removal of biofilm from an intracorporeal device, wherein said biofilm comprises or consists of bacteria of the genus Propionibacterium.
    Type: Application
    Filed: February 18, 2009
    Publication date: May 5, 2011
    Applicant: Biotechnology Research And Information Network, AG (B.R.A.I.N., AG)
    Inventors: Ute Dechert, Jurgen Eck, Michael Krohn
  • Patent number: 7872100
    Abstract: The present invention is concerned with the preparation of novel nitrile hydratases. These latter are preferably obtained from nonculturable organisms by means of a PCR-based screening, in metagenome DNA libraries, using special degenerate primers.
    Type: Grant
    Filed: March 10, 2005
    Date of Patent: January 18, 2011
    Assignee: B.R.A.I.N. Biotechnology Research and Information Networks AG
    Inventors: Stefan Verseck, Klaus Liebeton, Jurgen Eck
  • Patent number: RE47528
    Abstract: We have identified by molecular cloning a protease which originates from the larvae of Lucilia sericata and which was termed debrilase due to its activities useful for debridement of wounds.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: July 23, 2019
    Assignee: B.R.A.I.N. BIOTECHNOLOGY RESEARCH AND INFORMATION NETWORK AG
    Inventors: Frank Niehaus, Jürgen Eck, Renate Schulze, Michael Krohn